Press Release: Sanofis venglustat accepted for priority review in the US to treat type 3 Gaucher disease
Sanofi’s venglustat accepted for priority review in the US to treat type…
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreichs Ataxia on Monday, May 18, 2026
May 17, 2026 16:00 ET | Source: Design Therapeutics, Inc. CARLSBAD, Calif.,…
KuCoin Releases $2B Trust Project Annual Review, Marking Major Milestones in Security, Compliance, Transparency and User Protection
PROVIDENCIALES, Turks and Caicos Islands, May 15, 2026 /PRNewswire/ -- KuCoin, a…
SteelPower Capsules for Male Enhancement Support: Review the Ingredients & Where to Buy to Avoid Complaints
Aurora, CO, April 30, 2026 (GLOBE NEWSWIRE) -- These statements have not…
Privacy-led UX is becoming a prerequisite for AI adoption, new MIT Technology Review Insights report finds
Organizations that treat consent as an ongoing data relationship—not a one-time transaction—are…
NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification
Largo, FL, April 10, 2026 (GLOBE NEWSWIRE) -- A commission may be…
New Vitality, New Momentum: Xi’an’s 2025 Economic Review and Future Growth Prospects
Charting Xi'an's 2026 Vision: Driving Innovation-Led Transformation and High-Quality Development in Western…
International Fleet Review 2026 to Showcase India’s Naval Diplomacy and Maritime Partnerships
The Indian Navy is set to host the International Fleet Review 2026…
HTX Ventures Annual Review and Outlook: Regulatory Clarity, Asset Tokenization, and Institutional Adoption Resonate
PANAMA CITY, Jan. 28, 2026 /PRNewswire/ -- Recently, HTX Ventures, the global…
FDA Accepts LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease under Priority Review
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment…
